ArticleInternational journal of clinical pharmacy2025

Cost-effectiveness of benmelstobart-anlotinib-chemotherapy in extensive-stage small-cell lung cancer: A comparative analysis across United States and Chinese healthcare systems.

Junjie Wan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.